Dr. Thomas McCauley (UAB Physics PhD - Class of 1996) has assumed a Vice President position at Shire Pharmaceuticals. Dr. McCauley joined Shire in 2010 and heads its global nonclinical development.
In addition to his current focus on research and development of novel therapeutics for the Rare Disease, Neuroscience, Gastrointestinal, Internal Medicine and Regenerative Medicine business units, Tom has over thirteen years of experience in the biotechnology and pharmaceutical industries in preclinical and clinical discovery and development of biologic and small molecule drugs for indications in cardiovascular disease, hematology, oncology, inflammation and ophthalmology.
He holds undergraduate and graduate degrees from Cornell University, and received his PhD from the University of Alabama at Birmingham. Dr. McCauley's thesis work was in chemical vapor deposited diamond research. Previously Dr. McCauley worked at Brandies University and Argonne National Laboratory.
Physics Alumnus Thomas McCauley Heads Nonclinical Development Group at Shire Pharmaceuticals
Trailblazing Alumni
CAS News
April 19, 2015
More News
-
$2.8 million NSF grant to build nation’s first academic pathway for research administration careersUAB and partner institutions provide a playbook for launching research administration degree programs at 21 institutions in the United States and one in Namibia. -
Two UAB faculty awarded Alabama State Council on the Arts fellowship grantsSupporting individual artists is key to Alabama’s creative growth, according to the ASCA. James Braziel and Jillian Marie Browning, faculty members at UAB, each received a $7,500 grant. -
2026 winners of the College of Arts and Sciences Dean's Award for Excellence in TeachingThe Dean’s Award for Excellence in Teaching recognizes full-time, regular faculty members of the University of Alabama at Birmingham’s College of Arts and Sciences who have demonstrated exceptional accomplishments in teaching.